Medical Cytometrix Inc. (MCI) is developing a cloud-based software solution that automates blood disease detection, identification and classification.
No matter your location, or the time of day, you are can use our platform. It is available 24X7. All you need are digital images of your blood smear and an internet connection.
Our Cloud AI utilizes advancements in image processing, neural networks and deep learning to render results that you can trust.
Know that the AI analyzed results you receive are backed by thousands of hours of computer training, testing and expert review.
What We Do
Our Technology
The Problem
Manual review of a peripheral blood smear is one of the traditional methods used to diagnose benign or malignant hematologic disease. Today, this review is initially performed by a trained medical technologist who analyzes stained glass slides of peripheral blood in real time with a traditional microscope (referred to as “Slides”), or reviews digitized images of blood cells on a computer screen that have been digitized through an automated process. Cells that are suspect or cannot be interpreted with confidence by the medical technologist are typically forwarded to a pathologist, hematologist, or other highly trained specialist for a more definitive interpretation. The entire process is time consuming, labor intensive and often results in inconsistent interpretation of the Slide by a medical technologist and/or a pathologist. According to a 2014 study, lab tests diagnostics errors occur nearly 12 million times each year in the United States. That means 1 in 20 lab test results are misinterpreted or incorrect.
Our Solution
Medical Cytometrix Inc. (MCI) is finalizing Phase 1 development of a cloud-based AI system that will allow anyone, anywhere in the world, who can obtain or has access to a digital images of a blood smear, to upload those images into MCI’s web application, have MCI’s AI automatically analyze those images using MCI’s proprietary DL algorithms, and render a comprehensive report on the characteristics and classification of the analyzed blood cells. A physician will be able to trust and use the generated report/analysis to provide a suitable treatment to the patient from whom the blood was taken. Ultimately, MCI’s Technology will be able to automatically detect troublesome trends in malignant and atypical cell counts, giving the physician an added tool to personalize patient treatments before negative trends manifest into clinical disease states in patients. A physician can also use the near real-time technology to confirm that a specific medical treatment is having a positive effect on a specific patient. Access to MCI’s service will be available to anyone, anytime, anywhere and on any device (including mobile and pad devices). All that is required is for the user to be registered on MCI’s system, a digitized image of a blood smear, a commonly available internet connection, and a web browser.
MCI’s AI algorithms can analyze a blood smear in a manner of minutes not days. As an example, a physician could upload a blood smear image to MCI’s web application and have analyzed results, in the form of a report, emailed back to him/her within 5 minutes; irrespective of where the physician is located.
Our Difference
Any Time, Any Location
Consistent and Accurate
Lower Cost
Cutting Edge Technology
Quick Response
Global Network
Our Team
Team Members
Athan Georgiades MD
CMO, Founder & Board Chairman
Athan Georgiades MD, FACS, FICS is a board certified general and oncologic surgeon, who began his surgical career in 1986 at The Western Pennsylvania Hospital in Pittsburgh, Pennsylvania.
He has held innumerable leadership and teaching positions throughout the last 34 years, including his current positions as Chairman of Surgery for UPMC East and McKeesport Hospitals, President of GSA PC, Chairman of Independent Medical Doctors LLC, in Pittsburgh, Consultant Medical Director of Iasis Hospital in Cyprus and Chairman of Medical Cytometrix LLC in Vancouver.
He remains in active private practice, both in the US and overseas with an active EU license, and is a respected clinical health care consultant with a number of International clients, in Canada, Europe and the Middle East, including a large American based missionary group in the South Pacific.
He is actively engaged in Global Care International, on behalf of the University of Pittsburgh Medical Centre, and a number of outreach programs, which offer state of the art health care and consultative services that include telehealth, education, diagnostic and management services.
Lydia Contis MD
CSO, Founder & Board Member
Executive Imaging Director, and Director. Dr. Contis is the Medical Director, Hematology Laboratories, University of Pittsburgh Medical Center, and a member of the Division of Hematopathology at the University of Pittsburgh. Her specialty is Hematopathology, and has certifications in Anatomic and Clinical Pathology, and clinical expertise in Laboratory Medicine, adult and pediatric Hematopathology.
Parminder Singh P.Eng
CEO & Board Member
Parminder Singh (Par) has more than 25 years of technical, operations, international business, and management experience in public and private corporations. He has worked in variety of senior management roles in different sized organizations that span from undercapitalized start-ups to Fortune 100 multinational corporations. His background includes hands-on industry experience in software development, product development, online e-commerce & web services, intellectual property, innovation sourcing and video gaming, medical devices, advertising, & brand development. Parminder is currently the CEO of the Taal Innovation Advisors Inc. (“Taal”).
Taal is a boutique business consulting and innovation advisory firm that specializes in helping companies (big, small, public and private) grow and create value by transforming select technologies into commercially viable products and services and taking them to market through strategic global partnerships. Previously, Parminder served as the CEO of a disruptive start-up called LifeLens. LifeLens developed a personal bio-sensing wearable device that combines advancements in thin-film membranes, nanomaterials, and sensor miniaturization, to create the most advanced bio-sensing wearable device in the world today. The technology can accurately, in real-time and with clinical precision, sense, collect analyze and cross-correlate information about a user’s physiological state, their movement and activities, and the environment they are exposed. Prior to LifeLens, Parminder, served as the President of Intellectual Ventures Canada - a $6B private equity fund that invested in early-stage disruptive technologies. Parminder also served Managing Director of the Microsoft Canada Development Centre; the General Manager for Microsoft’s Home & Entertainment Division for Japan and the head of the Business Development group responsible for the global launch of Xbox and Xbox 360. Parminder has established three successful start-up companies and has held executive positions and consulted for a multitude of Fortune 500 companies including: Motorola, Microsoft, American Express, Flextronics, ATT, Boeing, Flextronics, AON Space, Hughes Aircraft Company, Space Systems Loral, and the Government of Canada. Parminder is an active investor in disruptive technologies and serves as an advisor to young entrepreneurs with big ideas. He holds a Bachelor’s degree in Electrical Engineering from the Technical University of Nova Scotia and lives in Surrey, British Columbia, Canada. He is married with three children, two dogs, and an occasional goldfish.
Konstantinos Plataniotis Ph.D.
CAO, Founder & Board Member
Konstantinos (Kostas) N. Plataniotis received his B. Eng. degree in Computer Engineering from University of Patras, Greece and his M.S. and Ph.D. degrees in Electrical Engineering from Florida Institute of Technology Melbourne, Florida. Dr. Plataniotis is currently a Professor with The Edward S. Rogers Sr. Department of Electrical and Computer Engineering at the University of Toronto in Toronto, Ontario, Canada, where he directs the Multimedia Laboratory. He holds the Bell Canada Endowed Chair in Multimedia since 2014. His research interests are primarily in the areas of image/signal processing, machine learning and adaptive learning systems, visual data analysis, multimedia and knowledge media, and communications systems. Dr. Plataniotis is a Fellow of IEEE, Fellow of the Engineering Institute of Canada, and registered professional engineer in Ontario.
Dr. Plataniotis has served as the Editor-in-Chief of the IEEE Signal Processing Letters. He was the Technical Co-Chair of the IEEE 2013 International Conference in Acoustics, Speech and Signal Processing, and he served as the inaugural IEEE Signal Processing Society Vice President for Membership (2014 -2016) and General Co-Chair for the 2017 IEEE GLOBALSIP. He served as the 2018 IEEE International Conference on Image Processing (ICIP 2018). He is the General Chair of the 2020 IEEE International Conference on IEEE International Conference on Blockchain and Cryptocurrency, May 3-6, 2020, Toronto, ON, Canada, and the 2021 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP 2021) General Co-Chair, June 2021, Toronto, ON, Canada. kostas.plataniotis@gmail.com
Panos Nasiopoulos Ph.D.
CSO & Board Member
Dr. Panos Nasiopoulos earned his Bachelor’s degree in Physics from the Aristotle University of Thessaloniki, Greece, and his Bachelor’s, Master’s, and Ph.D. degrees in Electrical and Computer Engineering from the University of British Columbia (UBC), Canada. He is a professor with the Department of Electrical and Computer Engineering and the former Director of the Institute for Computing, Information and Cognitive Systems and the Master of Software Systems at UBC. Before joining UBC, he was the President of Daikin Comtec US (co-founder of DVD) and Executive Vice President of Sonic Solutions. His research interests are primarily in the area of Digital Video Processing and Coding, he is the author or co-author of more than 250 research publications, and holds several patents.
Dr. Nasiopoulos is a registered member of the Association of Professional Engineers and Geoscientists of British Columbia (APEGBC), Canada. He is a Fellow of IEEE, a Fellow of the Canadian Academy of Engineering, and has been an active member of the Standards Council of Canada, MPEG, SMPTE and IEEE.
Ali Lotfi-Neyestanak Ph.D.
Lead, Technology Implementation
Ali Lotfi-Neyestanak Technology Manager. Dr. Lotfi received his Ph.D. degree in electrical engineering (with honor) from Iran University of Science and Technology, Tehran, Iran in 2004. He continued his research and studies in the Department of Electrical and Computer Engineering, University of Waterloo as a post-doctoral fellow. Before joining Cytometrix, he was a research scientist in the Department of Electrical and Computer Engineering, University of Waterloo. He has more than 20 years of experience in both industry and academia in different fields of electrical engineering.
Dr. Lotfi is a Senior Member of IEEE and has published two books, more than 120 papers in international journals and conferences. His main areas of research interest are biomedical image processing, video processing, microstrip antenna, microwave circuits, EMC and EMI, optimization and numerical methods in electromagnetic, and bio-electromagnetic.
Collaborations
Opportunities
There are currently no openings at Medical CytoMetrix Inc.
Are you interested in working for our company?
Contact usVisual Education
How to make a blood smear!
What is Hematology?
What is in blood?
Contact Us
For further information, please contact us:
Vancouver, British Columbia